Prof. Dr. S. Klein

Sandra Klein is a licensed pharmacist who earned her doctorate from the University of Frankfurt, Germany. She completed a postdoctoral fellowship at Eastman Chemical Company in Kingsport, TN, USA, and has been serving as a Professor of Pharmaceutical Technology at the University of Greifswald since 2010.

Her research primarily focuses on the development of oral dosage forms for paediatric and geriatric patients, along with the establishment of biorelevant in vitro methods and physiologically based pharmacokinetic (PBPK) models to predict the in vivo performance of these dosage forms in specific patient populations. Her work encompasses the formulation of poorly soluble drugs, taste-masked preparations, and controlled-release dosage forms. While the current emphasis is on paediatric patients across various age groups, her research interest also extends to geriatric patients and other special patient groups, particularly those with gastrointestinal disorders affecting drug absorption.

Beyond oral drug delivery, her research includes the development of biorelevant in vitro models for subcutaneous drug administration, as well as predictive release testing for lozenges, vaginal and rectal delivery systems, and accelerated release testing of inserts, implants and long-acting injectables.

Sandra Klein actively contributes to several professional organizations, including the American Association of Pharmaceutical Scientists (AAPS), the European Paediatric Formulation Initiative (EuPFI), the German Pharmaceutical Society (DPhG), and the International Association for Pharmaceutical Technology and Industrial Pharmacy (APV). She currently serves as President of the APV, is an Expert Member of the USP Expert Panel on New Advancements in Product Performance Testing and is part of the Formulations Expert Group of conect4children (c4c). Additionally, she holds the position of Editor-in-Chief of Pharmazie - An International Journal of Pharmaceutical Sciences.